APVO

APTEVO THERAPEUTICS INC

APVO·03835L702·US·Common Stock·Healthcare - Biotechnology-13D/G

APVO (APTEVO THERAPEUTICS INC) is held by 7 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($56,446), GEODE CAPITAL MANAGEMENT, LLC ($48,044), VANGUARD FIDUCIARY TRUST CO ($18,390). Net institutional sentiment: Mixed.

7
Holders
$127,860
Total Value
33% (3)
Consensus
1 buying - 2 selling
13F: Insider & Congress: Updated regularly
APVO

Smart Money Verdict

View all
Loading verdict
Held by 7 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Aug 14, 2026 · Congress none

ActivistCICVI Investments, Inc.6.3%Aug 14, 2026
ActivistNINIOWAVE, INC.12.2%Jun 22, 2026
ActivistCICVI Investments, Inc.8.2%Feb 17, 2026

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
12,713$56,4460.0%-63.81%
0
Decreased
10,821(-18.9%)$48,0440.0%-63.81%
0
Unchanged
4,142$18,3900.0%-63.81%
0
Decreased
730(-78.8%)$3,2420.0%-68.33%
0
Unchanged
360$1,5960.0%-94.11%
0
New
31$1380.0%-45.72%
17
Unchanged
1$40.0%-95.65%
0
APVOAPVOAPTEVO THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used